自噬
促红细胞生成素
视网膜色素上皮
下调和上调
糖尿病性视网膜病变
发病机制
细胞生物学
血-视网膜屏障
抗氧化剂
KEAP1型
医学
视网膜
癌症研究
氧化应激
活性氧
信号转导
链脲佐菌素
细胞凋亡
药理学
视网膜
视网膜病变
紧密连接
程序性细胞死亡
化学
生物
上皮
黄斑变性
免疫学
作者
Ha Young Jang,Hui Jiang,Jae Joon Park,Jun Wu,Weiyan Jiang,Jeong Hun Kim
标识
DOI:10.1177/0271678x261426919
摘要
Diabetic retinopathy (DR) is a progressive microvascular complication of diabetes, and emerging evidence suggests that the retinal pigment epithelium (RPE), a key component of the outer blood-retinal barrier (BRB), plays an active role in the early pathogenesis of DR. Here, we investigated whether erythropoietin (EPO) could stabilize the outer BRB by preserving RPE junctional integrity and enhancing antioxidant responses, thereby mitigating early progression in DR. Intravitreal (IVT) administration of EPO in streptozotocin (STZ)-induced diabetic mice mitigated morphological disruption of the RPE and restored its barrier integrity, as assessed by transepithelial electrical resistance (TEER) measurements using primary marmoset RPE cells. EPO treatment attenuated oxidative damage in the RPE, as indicated by reduced accumulation of 4-HNE and nuclear localization of 8-OHdG, and simultaneously upregulated Nrf2 target genes, HO-1 and NQO1. EPO activated the AMPK-ULK1 axis, which enhanced autophagy and facilitated Keap1 degradation, thereby promoting Nrf2 nuclear translocation and subsequent activation of antioxidant responses. These findings suggest that EPO exerts cytoprotective effects through the integrated activation of autophagy and Nrf2-mediated antioxidant response in the diabetic RPE. Our results provide the therapeutic potential of EPO as a protective strategy targeting outer BRB impairment in early DR.
科研通智能强力驱动
Strongly Powered by AbleSci AI